A comparative, randomized, contralateral study between the use of Mitomycin-C and accelerated cross-linking as adjuvant therapy after trans-epithelial all surface laser ablation for moderate to high myopia (ASLA-MMC vs. ASLA-XTRA): a pilot study

George D Kymionis, Vasileios Selimis, Konstantinos I Tsoulnaras, MHD Ghaith Mahayni, Ioannis M Aslanides
  • Expert Review of Ophthalmology, July 2018, Taylor & Francis
  • DOI: 10.1080/17469899.2018.1500458

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Dr Konstantinos I Tsoulnaras and Dr Ioannis Aslanides